<h4>Background</h4>Triple-negative breast cancer (TNBC) is a highly invasive type of breast cancers that is characterized by the absence of hormone receptors and HER2 protein, thereby relying mostly on surgical intervention and cytotoxic chemotherapy. This evidence concerns the gene ERBB2 and breast carcinoma.